Reply to “Rationalizing and mitigating the risk of live-attenuated dengue vaccines”
Thank you for sharing the letter discussing our recently published case report, “Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction” [1]. We appreciate the authors’ thoughtful analysis and their comparison with yellow fever vaccine–associated viscerotropic disease (YEL-AVD).
Authors
- Pinyo Rattanaumpawan (ORCID: https://orcid.org/0000-0002-2964-6732)
Institutions
- Siriraj Hospital (TH)
- Mahidol University (TH)
- Mahidol Oxford Tropical Medicine Research Unit (TH)
Publication Details
- Journal
- International Journal of Infectious Diseases
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.ijid.2025.108243
- Citations
- 1
- Primary Topic
- Mosquito-borne diseases and control
- Type
- article
- Field-Weighted Citation Impact
- 1.88